SANRITATUG
UNII Q9T9JY086W

Substance Identification & Data

This profile provides standardized clinical and technical data for Sanritatug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Q9T9JY086W.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3028478-15-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

Q9T9JY086W

CAS Registry Number

3028478-15-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SANRITATUG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C179569

National Cancer Institute reference terminology for clinical and research data.

INN ID

13577

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sanritatug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SANRITATUG

Common Names & Synonyms

H-GAMMA1 HEAVY CHAIN CHIMERIC (1-449) (VH MUSMUS/HOMSAP (MUS MUSCULUS IGHV4-1*02 (91.8%) -(IGHD) -IGHJ2*01 (100%)/HOMO SAPIENS IGHV3-48*01 (73.5%) -(IGHD) -IGHJ4*01 (85.7%) L123>T (114), V124>L (115), CDR-IMGT (8.8.12) (26-33.51-58.97-108)) (1-119) -HOMO SAPIENS IGHG1*01 (100%) G1M17,1 CH1 K120, CH3 D12, L14 (CH1 K120 (216) (120-217), HINGE 1-15 (218-232), CH2 (233-342), CH3 D12 (358), L14 (360) (343-447), CHS (448-449)) (120-449)), (222-218')-DISULFIDE WITH L-KAPPA LIGHT CHAIN CHIMERIC (1'-218') (V-KAPPA MUSMUS/HOMSAP (MUS MUSCULUS IGKV3-12*01 (85.9%) -IGKJ4*01 (100%)/HOMO SAPIENS IGKV3D-11*02 (68.1%) -IGKJ2*02 (90.9%) Q120>S (104'), CDR-IMGT (10.3.9) (27'-36'.54'-56'.93'-101')) (1'-111') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (157'), V101 (195')) (112'-218')); DIMER (228-228'':231-231'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD38 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL SG301 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SG301 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CD38 (ADP-RIBOSYL CYCLASE 1, CYCLIC ADP-RIBOSE HYDROLASE 1, CADPR HYDROLASE 1, CADPR1)), CHIMERIC MONOCLONAL ANTIBODY (SANRITATUG)

SANRITATUG [INN]